Log in to save to my catalogue

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4461862

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

About this item

Full title

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Publisher

United States: American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2013-11, Vol.342 (6158), p.592-598

Language

English

Formats

Publication information

Publisher

United States: American Association for the Advancement of Science

More information

Scope and Contents

Contents

Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site φ, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is t...

Alternative Titles

Full title

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4461862

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4461862

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.1243283

How to access this item